Keywords: botox, sbla, filed, chronic, migraine, drugmaker, allergan

Botox sBLA to be filed for chronic migraine

Article | 22 September 2008

Print This

US drugmaker Allergan has reported promising top-line results from an analysis of two Phase III trials exploring the use of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in